Seqirus Announces Major Advances in Pandemic Preparedness

Seqirus Announces Major Advances in Pandemic Preparedness


Seqirus, a global leader in the prevention of influenza, announced today that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing facility in Holly Springs, North Carolina, has delivered a four-fold increase in seasonal influenza vaccine output in just two years, strengthening the United States' capacity to respond to pandemic threats. Seqirus marked the 10th anniversary of their pandemic partnership with the U.S. Government by hosting Health and Human Services Secretary Dr. Tom Price at the Holly Springs, N.C. production site.



from Biotech News